Posterior retroperitoneoscopic resection of recurrent nonseminomatous tumor mass
| Autor: | Patrick H. J. Hemmer, Çiğdem Öztürk, Schelto Kruijff, Harald J. Hoekstra, Jourik A. Gietema |
|---|---|
| Přispěvatelé: | Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE) |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
tumor AcademicSubjects/MED00910 medicine.medical_treatment 030232 urology & nephrology laparoscopy Case Report testis residual Resection 03 medical and health sciences Retroperitoneal tumor 0302 clinical medicine Laparotomy nonseminoma medicine Retroperitoneal space jscrep/0170 Stage (cooking) Laparoscopy retroperitoneal medicine.diagnostic_test business.industry Combination chemotherapy Retroperitoneal Neoplasm Surgery medicine.anatomical_structure 030220 oncology & carcinogenesis business |
| Zdroj: | Journal of Surgical Case Reports Journal of surgical case reports, 2020(7), 1-4. Oxford University Press |
| ISSN: | 2042-8812 |
| DOI: | 10.1093/jscr/rjaa122 |
| Popis: | Treatment of stage II–IV nonseminomatous testicular germ cell tumors (NSTGCTs) consists of cisplatin-based combination chemotherapy and, when present, resection of residual retroperitoneal tumor mass (RRTM) by conventional laparotomy or laparoscopy. In case of a retroperitoneal recurrence, a second conventional or laparoscopic procedure may be challenging. A case of late relapse after prior conventional resection of a RRTM and tailor-made surgical management with a posterior retroperitoneoscopic resection (PRR) is reported. A posterior retroperitoneoscopic RRTM resection was performed in a 26-year-old male with a history of stage IIC NSTGCT, presenting with a late left-sided retroperitoneal relapse, 6 years after initial treatment. Postoperative course was uneventful and at 1-year follow-up the patient had no evidence of disease. Reoperative surgery by a minimal invasive retroperitoneoscopic approach should be considered as an alternative for patients with a recurrent retroperitoneal tumor mass of a NSTGCT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |